Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Net Cash Flow (2023 - 2025)

Historic Net Cash Flow for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to -$9.6 million.

  • Profound Medical's Net Cash Flow fell 2960.37% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 5933.92%. This contributed to the annual value of $31.2 million for FY2024, which is 24982.5% up from last year.
  • Per Profound Medical's latest filing, its Net Cash Flow stood at -$9.6 million for Q3 2025, which was down 2960.37% from -$13.7 million recorded in Q2 2025.
  • Profound Medical's Net Cash Flow's 5-year high stood at $29.6 million during Q4 2024, with a 5-year trough of -$26.4 million in Q3 2023.
  • In the last 3 years, Profound Medical's Net Cash Flow had a median value of -$7.4 million in 2024 and averaged -$2.0 million.
  • Within the past 5 years, the most significant YoY rise in Profound Medical's Net Cash Flow was 49261.42% (2024), while the steepest drop was 23326.82% (2024).
  • Quarter analysis of 3 years shows Profound Medical's Net Cash Flow stood at -$7.5 million in 2023, then skyrocketed by 492.61% to $29.6 million in 2024, then crashed by 132.53% to -$9.6 million in 2025.
  • Its Net Cash Flow stands at -$9.6 million for Q3 2025, versus -$13.7 million for Q2 2025 and -$8.6 million for Q1 2025.